A Made-in-China Pandemic
The COVID-19 pandemic should be a wake-up call for a world that has accepted China’s lengthening shadow over global supply chains for far too long. Only by reducing China’s global economic influence – beginning in the pharmaceutical sector – can the world be kept safe from the country's political pathologies.
NEW DELHI – The new COVID-19 coronavirus has spread to more than 100 countries – bringing social disruption, economic damage, sickness, and death – largely because authorities in China, where it emerged, initially suppressed information about it. And yet China is now acting as if its decision not to limit exports of active pharmaceutical ingredients (APIs) and medical supplies – of which it is the dominant global supplier – was a principled and generous act worthy of the world’s gratitude.
When the first clinical evidence of a deadly new virus emerged in Wuhan, Chinese authorities failed to warn the public for weeks and harassed, reprimanded, and detained those who did. This approach is no surprise: China has a long history of “killing” the messenger. Its leaders covered up severe acute respiratory syndrome (SARS), another coronavirus, for over a month after it emerged in 2002, and held the doctor who blew the whistle in military custody for 45 days. SARS ultimately affected more than 8,000 people in 26 countries.
This time around, the Communist Party of China’s proclivity for secrecy was reinforced by President Xi Jinping’s eagerness to be perceived as an in-control strongman, backed by a fortified CPC. But, as with the SARS epidemic, China’s leaders could keep it under wraps for only so long. Once Wuhan-linked COVID-19 cases were detected in Thailand and South Korea, they had little choice but to acknowledge the epidemic.
To continue reading, register now.
Already have an account? Log in